Wiley, Alimentary Pharmacology and Therapeutics, 5(13), p. 603-608, 1999
DOI: 10.1046/j.1365-2036.1999.00514.x
Full text: Download
Background: In view of the changing nature of transjugular liver biopsy, we performed an audit of the safety, adequacy and clinical impact of such biopsies in our centre over a 2-year period from 1995 to 1997. Methods: One hundred and fifty-seven transjugular biopsies were carried out in 145 patients, with prothrombin time > 5 s over control and/or platelet count